We are live on ! Find out more
NVAX icon

Novavax
NVAX

81 hedge funds and large institutions have $35.7M invested in Novavax in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

166% more call options, than puts

Call options by funds: $13.6M | Put options by funds: $5.12M

0.88% more ownership

Funds ownership: 28.74% → 29.62% (+0.88%)

0% more funds holding

Funds holding: 81 → 81 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

10% less capital invested

Capital invested by funds: $39.7M → $35.7M (-$3.95M)

Holders
81
Holders Change
–
Holders Change %
0%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
31
Reduced
10
Closed
11
Calls
$13.6M
Puts
$5.12M
Net Calls
+$8.51M
Net Calls Change
-$6.3M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$1.51M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$800K
3
BlackRock
BlackRock
New York
+$479K
4
WG
Winton Group
United Kingdom
+$418K
5
Northern Trust
Northern Trust
Illinois
+$271K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$877K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$590K
3
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$510K
4
ARTA
A.R.T. Advisors
New York
-$435K
5
Deutsche Bank
Deutsche Bank
Germany
-$409K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
51
Advisor Group
Arizona
$35K +$26K +4,755 +196%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$34K +$12.3K +2,246 +51%
Legal & General Group
53
Legal & General Group
United Kingdom
$31K +$5.5K +1,004 +20%
Deutsche Bank
54
Deutsche Bank
Germany
$30K -$409K -74,810 -92%
Victory Capital Management
55
Victory Capital Management
Texas
$20K +$21.7K +3,973 New
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$16.4K +$6.35K +1,161 +55%
CG
57
Cutler Group
California
$12K +$13.1K +2,400 New
Canada Life
58
Canada Life
Manitoba, Canada
$8K -$7.59K -1,387 -47%
AIP
59
Ameritas Investment Partners
Nebraska
$8K – – –
Zurich Cantonal Bank
60
Zurich Cantonal Bank
Switzerland
$7K – – –
BFEC
61
Benjamin F. Edwards & Company
Missouri
$3K – – –
FCMT
62
Founders Capital Management (Texas)
Texas
$3K – – –
VNA
63
Valley National Advisers
Pennsylvania
$2K – – –
MAM
64
Meeder Asset Management
Ohio
$2K +$1.29K +235 +93%
WT
65
Whittier Trust
California
$1K -$274 -50 -29%
ASN
66
Advisory Services Network
Georgia
$1K – – –
BBHC
67
Brown Brothers Harriman & Co
New York
$1K – – –
Daiwa Securities Group
68
Daiwa Securities Group
Japan
$1K – – –
EWM
69
Edge Wealth Management
New York
$1K – – –
GWM
70
Geneos Wealth Management
Colorado
$1K – – –
GRP
71
Global Retirement Partners
California
$1K – – –
Northwestern Mutual Wealth Management
72
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Fifth Third Bancorp
73
Fifth Third Bancorp
Ohio
$1K +$547 +100 New
RE
74
RBC Europe
United Kingdom
$823 – – –
APA
75
American Portfolios Advisors
New York
$753 – – –
1 2
3
4

NVAX Hedge Fund Activity: Q3 2019 in Review

81 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2019, worth a combined $35.7M — down 10% from $39.7M a quarter earlier.

Fund positioning in NVAX was balanced in Q3 2019: 11 funds opened new positions, 11 closed out, 31 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.51M. The largest seller was Morgan Stanley, cutting an estimated $877K.

  • 81 institutional investors held Novavax (NVAX) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $35.7M of Novavax stock for Q3 2019, down 10% quarter-over-quarter.
  • 11 funds opened new Novavax positions in Q3 2019 and 11 closed out, a net change of 0 holders.
  • The largest Novavax buyer in Q3 2019 was JP Morgan Chase, an estimated $1.51M added.
  • The largest Novavax seller in Q3 2019 was Morgan Stanley, an estimated $877K sold.

Based on aggregated 13F filings for Q3 2019.